Friday, November 22, 2019 9:01:12 AM
" (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed contracts with six new clients in Texas.
“We are very pleased to welcome six new clients to Reliq’s iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These six new clients include physician practices, home health agencies, a home hospice organization and a pharmacy network with multiple locations across South Texas. These healthcare organizations will be using the iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) modules, and in some cases the iUGO Home product line for specific patient populations. Together these six care providers serve over 3,000 chronic disease and palliative patients. We expect to go live with all six clients in December.”
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
Recent RHT News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - RHT • PR Newswire (Canada) • 01/17/2024 01:03:00 PM
- Canadian Investment Regulatory Organization Trading Halt - RHT • PR Newswire (Canada) • 01/17/2024 01:01:00 PM
- Another Day, Another Healthcare Stock Finding Success • AllPennyStocks.com • 12/13/2023 06:40:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM